– Designación de terapia innovadora para los comprimidos sublinguales de Sanbexin otorgada por la Administración de Alimentos y Medicamentos de Estados Unidos NANJING, China, 16 de septiembre de 2024 /PRNewswire/ — El 2 de septiembre […]
Tag: Pharmaceuticals
TORL BioTherapeutics Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2024 European Society of Medical Oncology Congress
TORL-1-23 Demonstrates Clinically Meaningful, Durable and Confirmed Responses with a Generally Manageable Safety Profile in Patients with Claudin 6 Positive (CLDN6+) Platinum-Resistant Ovarian Cancer Expansion Cohorts in Patients with Ovarian, Non-Small Cell Lung Cancer, and […]
RYBREVANT® (amivantamab-vmjw) plus chemotherapy show 49 percent overall response rate in metastatic colorectal cancer
Median duration of response reaches 7.4 months with combination treatment in patients with aggressive form of disease New results show potential of RYBREVANT® beyond lung cancer BARCELONA, Sept. 14, 2024 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) today […]
Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients
STOCKHOLM, Sept. 13, 2024 /PRNewswire/ — Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in the ongoing North American Phase 3 study for MOB-015 […]
TCI revolutioniert das Gewichtsmanagement mit bahnbrechender GLP-1-Innovation
TAIPEI, 12. September 2024 /PRNewswire/ — TCI Co. Ltd. („TCI”, 8436.TWO), seit über 40 Jahren ein weltweit führender Anbieter von ODM-Gesundheits- und Kosmetikprodukten, stellt seine innovative GLP-1-Formel vor, eine natürliche Mischung aus Pflanzenextrakten, Probiotika und Präbiotika, […]
